Table 5 Univariate and multivariate Cox regression analysis of the identification of patients with chronic heart failure at increased risk of total mortality.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| p Value | HR (95% CI) | p Value | HR (95% CI) | |
| WR | <0.001 | 1.049 (1.026 to 1.027) | 0.002 | 1.044 (1.015 to 1.074) |
| H/M (d) | 0.001 | 0.112 (0.032 to 0.396) | — | — |
| Radionuclide LVEF | 0.015 | 0.943 (0.899 to 0.989) | 0.054 | 0.946 (0.895 to 1.001) |
| LVEDD | 0.031 | 1.047 (1.004 to 1.091) | 0.44 | 1.022 (0.946 to 1.063) |
| LAD | 0.035 | 1.050 (1.003 to 1.098) | 0.93 | 1.003 (0.946 to 1.063) |
| Plasma norepinephrine level | 0.051 | 1.001 (1.000 to 1.002) | — | — |
| Lown's grade | 0.107 | 1.301 (0.945 to 1.791) | — | — |
| H/M (e) | 0.18 | 0.404 (0.106 to 1.533) | — | — |
–, Not included in the multivariate analysis; H/M (d), the heart‐to‐mediastimum metaiodobenzylguanidine (MIBG) uptake ratio on the delayed images; H/M (e), the heart‐to‐mediastimum MIBG uptake ratio on the early images; LAD, left atrial dimension; LVEDD, left ventricular end‐diastolic dimension; LVEF, left ventricular ejection fraction; WR, washout rate.